Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients

Peptide receptor radionuclide therapy (PRRT) is a well-established treatment in somatostatin receptor-expressing neuroendocrine tumours (NETs). The safety and efficacy of PRRT in >79 years old patients (EP) have not been systematically investigated. All patients with inoperable/metastatic/progres...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2021-12, Vol.13 (24), p.6290
Hauptverfasser:	Theiler, Deborah, Cattaneo, Marco, Dierickx, Lawrence O, Igaz, Peter, Grozinsky-Glasberg, Simona, Bournaud, Claire, O'Dorisio, Thomas, O'Dorisio, M Sue, Wild, Damian, Christ, Emanuel, Nicolas, Guillaume P
Format:	Artikel
Sprache:	eng
Schlagworte:	Age groups Colon Drug dosages Granulocytes Hematology Hemoglobin Histology Laboratories Life span Lymphocytes Metastases Metastasis Neuroendocrine tumors Neutrophils Patients Peptides Quality of life Radiation therapy Safety Somatostatin Survival Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!